Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al

Justia Dockets & Filings Third Circuit Delaware District Court Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al

Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al

Plaintiff:	Novartis Pharmaceuticals Corporation
Defendant:	Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit III, Laurus Labs Limited, Laurus Generics Inc., Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.
Case Number:	1:2021cv01330
Filed:	September 20, 2021
Court:	US District Court for the District of Delaware
Presiding Judge:	Leonard P Stark
Nature of Suit:	Patent - Abbreviated New Drug Application(ANDA)
Cause of Action:	35 U.S.C. § 271
Jury Demanded By:	None

RSS Track this Docket

Docket Report

This docket was last retrieved on September 27, 2022. A more recent docket listing may be available from PACER.

Date Filed	Document Text
November 18, 2021	Filing 50 ANSWER to #31 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 17, 2021	Filing 49 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham)(Silver, Daniel)
November 17, 2021	Filing 48 DECLARATION of Service of Macleods Pharma USA, Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
November 17, 2021	Filing 47 DECLARATION of Service of Macleods Pharmaceuticals Ltd. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
November 15, 2021	Filing 46 ANSWER to #1 Complaint,, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc..(Seaman, John)
November 15, 2021	Filing 45 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Seaman, John)
November 15, 2021	Filing 44 NOTICE of Appearance by April M. Kirby on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Kirby, April)
November 15, 2021	Filing 43 NOTICE of Appearance by John M. Seaman on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Seaman, John)
November 12, 2021	Filing 42 ANSWER to #24 Answer to Complaint,, Counterclaim, of Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 12, 2021	Filing 41 [SEALED] OPENING BRIEF in Support re #40 MOTION to Dismiss for Failure to State a Claim Torrent's Counterclaims Against Novartis's U.S. Patent Nos. 9,517,226, 9,937,143, 11,135,192 AND 11,058,667 filed by Novartis Pharmaceuticals Corporation.Answering Brief/Response due date per Local Rules is 11/29/2021. (Attachments: #1 Certificate of Service)(Silver, Daniel)
November 12, 2021	Filing 40 MOTION to Dismiss for Failure to State a Claim Torrent's Counterclaims Against Novartis's U.S. Patent Nos. 9,517,226, 9,937,143, 11,135,192 AND 11,058,667 - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Silver, Daniel)
November 12, 2021	Filing 39 ANSWER to #22 Answer to Complaint,, Counterclaim, of Hetero USA Inc., Hetero Labs Limited, and Hetero Labs Limited Unit III by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 12, 2021	Filing 38 [SEALED] OPENING BRIEF in Support re #37 MOTION to Dismiss for Failure to State a Claim Hetero's Counterclaims Against Novartis's U.S. Patent Nos. 9,517,226, 9,937,143, 11,135,192 AND 11,058,667 filed by Novartis Pharmaceuticals Corporation.Answering Brief/Response due date per Local Rules is 11/29/2021. (Attachments: #1 Certificate of Service)(Silver, Daniel)
November 12, 2021	Filing 37 MOTION to Dismiss for Failure to State a Claim Hetero's Counterclaims Against Novartis's U.S. Patent Nos. 9,517,226, 9,937,143, 11,135,192 AND 11,058,667 - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Proposed Order)(Silver, Daniel)
November 12, 2021	Filing 36 ANSWER to #28 Answer to Complaint, Counterclaim of Laurus Labs Limited and Laurus Generics Inc. by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 12, 2021	Filing 35 ANSWER to #26 Answer to Complaint, Counterclaim of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 12, 2021	Filing 34 ANSWER to #20 Answer to Complaint, Counterclaim of Alkem Laboratories Ltd. by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
November 8, 2021	Filing 33 NOTICE of Withdrawal of Beth A. Swadley by Laurus Generics Inc., Laurus Labs Limited (Poff, Adam)
October 29, 2021	Pro Hac Vice Attorney Kenneth S. Canfield for Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc., Torrent Pharma Inc., and Torrent Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
October 28, 2021	Filing 32 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma USA Inc.. (Hitch, Cortlan)
October 28, 2021	Filing 31 ANSWER to #1 Complaint,, , COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma USA Inc..(Hitch, Cortlan)
October 27, 2021	Filing 30 MOTION for Pro Hac Vice Appearance of Attorney Edward D. Pergament, Dmitry V. Shelhoff, Kenneth S. Canfield, and Julia Kim - filed by Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Attachments: #1 Certification, #2 Certification, #3 Certification, #4 Certification)(Ormerod, Eve)
October 27, 2021	SO ORDERED, re #30 MOTION for Pro Hac Vice Appearance of Attorney Edward D. Pergament, Dmitry V. Shelhoff, Kenneth S. Canfield, and Julia Kim filed by Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit III, Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. Signed by Judge Leonard P. Stark on 10/27/21. (ntl)
October 27, 2021	Pro Hac Vice Attorney Christopher D. Jones for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
October 25, 2021	Pro Hac Vice Attorneys Bryan D. Beel and Autumn N. Nero for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
October 22, 2021	Filing 29 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Laurus Labs Ltd. for Laurus Generics Inc. filed by Laurus Generics Inc.. (Swadley, Beth)
October 22, 2021	Filing 28 ANSWER to #1 Complaint,, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Laurus Generics Inc., Laurus Labs Limited.(Swadley, Beth)
October 22, 2021	Filing 27 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories S.A. for Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Stamoulis, Stamatios)
October 22, 2021	Filing 26 ANSWER to #1 Complaint,, , COUNTERCLAIM against All Plaintiffs by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Stamoulis, Stamatios)
October 22, 2021	Filing 25 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Belgam, Neal)
October 22, 2021	Filing 24 ANSWER to #1 Complaint,, Defendant Torrent Pharma, Inc. and Torrent Pharmaceuticals, Ltd.'s Answer, Defenses, and Counterclaims, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Torrent Pharmaceuticals Ltd., Torrent Pharma Inc.. (Attachments: #1 Exhibit 1-4)(Ormerod, Eve)
October 22, 2021	Filing 23 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA Inc. filed by Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc.. (Belgam, Neal)
October 22, 2021	Filing 22 ANSWER to #1 Complaint,, Defendants Hetero USA Inc., Hetero Labs Limited, and Hetero Labs Limited Unit III's Answer, Defenses, and Counterclaims, COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Hetero Labs Limited Unit III, Hetero USA Inc., Hetero Labs Limited. (Attachments: #1 Exhibit 1-4)(Ormerod, Eve)
October 22, 2021	Filing 21 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Alkem Laboratories Ltd.. (Dorsney, Kenneth)
October 22, 2021	Filing 20 ANSWER to #1 Complaint,, , COUNTERCLAIM against All Plaintiffs by Alkem Laboratories Ltd..(Dorsney, Kenneth)
October 21, 2021	Filing 19 DECLARATION of Service of Aurobindo Pharma Ltd. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 21, 2021	SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Bryan D. Beel, and Christopher D. Jones filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Signed by Judge Leonard P. Stark on 10/21/21. (ntl)
October 11, 2021	Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Bryan D. Beel, and Christopher D. Jones - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Stamoulis, Stamatios)
October 8, 2021	Filing 17 DECLARATION of Service of Torrent Pharmaceuticals Ltd. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 16 DECLARATION of Service of Torrent Pharma Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 15 DECLARATION of Service of Laurus Labs Limited by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 14 DECLARATION of Service of Laurus Generics Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 13 DECLARATION of Service of Hetero USA Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 12 DECLARATION of Service of Hetero Labs Limited by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 11 DECLARATION of Service of Hetero Labs Limited Unit III by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 10 DECLARATION of Service of Dr. Reddy's Laboratories, Ltd. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 9 DECLARATION of Service of Dr. Reddy's Laboratories, Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 8 DECLARATION of Service of Alkem Laboratories Ltd. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
October 8, 2021	Filing 7 Return of Service Executed by Novartis Pharmaceuticals Corporation. Aurobindo Pharma USA Inc. served on 10/7/2021, answer due 10/28/2021. (Silver, Daniel)
September 22, 2021	Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
September 20, 2021	Filing 6 Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Ltd. on 9/20/2021; Aurobindo Pharma Ltd. on 9/20/2021; Aurobindo Pharma USA Inc. on 9/20/2021; Dr. Reddy's Laboratories, Inc. on 9/20/2021; Dr. Reddy's Laboratories, Ltd. on 9/20/2021; Hetero Labs Limited on 9/20/2021; Hetero Labs Limited Unit III on 9/20/2021; Hetero USA Inc. on 9/20/2021; Laurus Generics Inc. on 9/20/2021; Laurus Labs Limited on 9/20/2021; Macleods Pharma USA, Inc. on 9/20/2021; Macleods Pharmaceuticals Ltd. on 9/20/2021; Torrent Pharma Inc. on 9/20/2021; Torrent Pharmaceuticals Ltd. on 9/20/2021. (Attachments: #1 Summons Issued, #2 Summons Issued, #3 Summons Issued, #4 Summons Issued, #5 Summons Issued, #6 Summons Issued, #7 Summons Issued, #8 Summons Issued, #9 Summons Issued, #10 Summons Issued, #11 Summons Issued, #12 Summons Issued, #13 Summons Issued)(apk)
September 20, 2021	Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk)
September 20, 2021	Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,096,918. (apk)
September 20, 2021	Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ANDA FORM. Date of Expiration of Patent: 11/08/2026.Thirty Month Stay Deadline: 7/7/2023. (apk)
September 20, 2021	Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
September 20, 2021	Filing 1 COMPLAINT filed against Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hetero Labs Limited, Hetero Labs Limited Unit III, Hetero USA Inc., Laurus Generics Inc., Laurus Labs Limited, Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3702987.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Web	[ Unicourt \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By:	Alexandra M. Joyce
Represented By:	Daniel M. Silver
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Alkem Laboratories Ltd.
Represented By:	Kenneth Laurence Dorsney
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Aurobindo Pharma USA Inc.
Represented By:	Cortlan S. Hitch
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Aurobindo Pharma Ltd.
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Dr. Reddy's Laboratories, Inc.
Represented By:	Autumn N. Nero
Represented By:	Bryan D. Beel
Represented By:	Christopher D. Jones
Represented By:	Stamatios Stamoulis
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Dr. Reddy's Laboratories, Ltd.
Represented By:	Autumn N. Nero
Represented By:	Bryan D. Beel
Represented By:	Christopher D. Jones
Represented By:	Stamatios Stamoulis
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Hetero USA Inc.
Represented By:	Neal C. Belgam
Represented By:	Kenneth S. Canfield
Represented By:	Eve H. Ormerod
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Hetero Labs Limited
Represented By:	Neal C. Belgam
Represented By:	Kenneth S. Canfield
Represented By:	Eve H. Ormerod
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Hetero Labs Limited Unit III
Represented By:	Neal C. Belgam
Represented By:	Kenneth S. Canfield
Represented By:	Eve H. Ormerod
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Laurus Labs Limited
Represented By:	Beth Ann Swadley
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Laurus Generics Inc.
Represented By:	Beth Ann Swadley
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Macleods Pharmaceuticals Ltd.
Represented By:	April M. Kirby
Represented By:	John M. Seaman
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Macleods Pharma USA, Inc.
Represented By:	April M. Kirby
Represented By:	John M. Seaman
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Torrent Pharma Inc.
Represented By:	Neal C. Belgam
Represented By:	Kenneth S. Canfield
Represented By:	Eve H. Ormerod
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Torrent Pharmaceuticals Ltd.
Represented By:	Neal C. Belgam
Represented By:	Kenneth S. Canfield
Represented By:	Eve H. Ormerod
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?